TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
10.97
-0.08 (-0.72%)
At close: Aug 15, 2025, 11:55 AM
TransCode Therapeutics Revenue
TransCode Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, TransCode Therapeutics generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
7
Market Cap
9.15M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|